Indeed, there was a significant correlation between levels of AXIN2 and the EMT markers VIM (Vimentin) and ZEB1 (Zinc Finger E-Box Binding Homeobox 1), which again was lost in tumor samples from Metformin-taking lung cancer patients (Supplementary Fig. S2). This evidence concerns the gene VIM and lung cancer.